MILLIPORE (U.K.) LIMITED
Get an alert when MILLIPORE (U.K.) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-01-05 (in 8mo)
Last made up 2025-12-22
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£150M
-5.9% vs 2023
Employees
126
+6.8% vs 2023
Profit before tax
£22M
+713.4% vs 2023
Name history
Renamed 1 time since incorporation
- MILLIPORE (U.K.) LIMITED 2001-02-23 → present
- INTERCEDE 1668 LIMITED 2000-12-22 → 2001-02-23
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £22,343,000 | £26,655,000 | |
| Operating profit | £1,216,000 | £5,385,000 | |
| Profit before tax | £2,759,000 | £22,441,000 | |
| Net profit | £2,621,000 | £20,605,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £159,760,000 | £150,343,000 | |
| Net assets | £159,707,000 | £150,312,000 | |
| Equity | £159,707,000 | £150,312,000 | |
| Average employees | 118 | 126 | |
| Wages | £5,333,000 | £6,756,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 5.4% | 20.2% | |
| Net margin | 11.7% | 77.3% | |
| Return on capital employed | 0.8% | 3.6% | |
| Current ratio | 9.49x | 9.01x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which the directors consider to be appropriate for the following reasons. The Directors have prepared cash flow forecasts covering at least 12 months from the date of signing these financial statements. The company will have sufficient funds through its central cash pooling account to meet its liabilities as they fall due for that period. ... Consequently, the directors are confident that the Company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”
Group structure
- MILLIPORE (U.K.) LIMITED · parent
- Merck Life Science UK Limited 100%
- Merck Performance Materials Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| A G SECRETARIAL LIMITED | Corporate Secretary | 2008-02-01 | — | — |
| BIRKETT, Adrian | Director | 2024-05-08 | Dec 1964 | British |
| MASSEY, Alison Eve | Director | 2023-03-01 | Sep 1964 | British |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MITRE SECRETARIES LIMITED | Corporate Nominee Secretary | 2000-12-22 | 2008-02-01 |
| ALLEN, Kathleen Beaumont | Director | 2004-12-15 | 2008-02-12 |
| BIRO, Peter | Director | 2017-07-01 | 2023-03-01 |
| DOCKSEY, Steven John | Director | 2001-02-23 | 2003-09-08 |
| EWEN, Barry | Director | 2012-10-01 | 2013-01-14 |
| JACKSON, Victor Mark | Director | 2017-07-01 | 2024-05-08 |
| JEANS, David Richard | Director | 2015-03-31 | 2017-06-30 |
| KAUFFER, Didier Charles | Director | 2008-06-10 | 2012-10-01 |
| KRATZER, Stefan | Director | 2012-10-01 | 2017-07-01 |
| LARY, J Edward | Director | 2003-09-08 | 2005-04-01 |
| LUNGER, Francis | Director | 2001-02-23 | 2004-12-15 |
| MATTACCHIONE, Anthony Laurence | Director | 2008-06-10 | 2012-10-01 |
| MILEWICH, Daniel Abram | Director | 2008-06-10 | 2012-10-01 |
| RICH, Michael William | Nominee Director | 2000-12-22 | 2001-02-23 |
| RUDIN, Jeffrey | Director | 2001-02-23 | 2008-06-10 |
| STURNI, Claude | Director | 2005-04-01 | 2008-06-10 |
| VERRALL, Mark Andrew, Dr | Director | 2013-01-14 | 2015-03-31 |
| WARNER, William | Nominee Director | 2000-12-22 | 2001-02-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Sigma-Aldrich Company Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-08-07 | Active |
| Safc Biosciences Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-12-06 | Ceased 2019-08-07 |
| Sigma Chemical Company Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-12-06 | Ceased 2019-08-07 |
| Millipore Uk Holdings Llp | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-08-07 |
| Merck Kgaa | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2016-12-06 |
Filing timeline
Last 20 of 125 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-17 | AA | accounts | Accounts with accounts type full | |
| 2024-12-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-08 | AA | accounts | Accounts with accounts type full | |
| 2024-06-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-05 | AP01 | officers | Appoint person director company with name date | |
| 2023-12-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-17 | AA | accounts | Accounts with accounts type full | |
| 2023-03-01 | AP01 | officers | Appoint person director company with name date | |
| 2023-03-01 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-26 | AA | accounts | Accounts with accounts type full | |
| 2021-12-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-17 | AA | accounts | Accounts with accounts type full | |
| 2020-12-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-12-03 | AA | accounts | Accounts with accounts type full | |
| 2020-06-29 | CH01 | officers | Change person director company with change date | |
| 2019-12-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2019-12-17 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2019-12-17 | PSC02 | persons-with-significant-control | Notification of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+19.3%
£22,343,000 £26,655,000
-
Cash
—
Not reported
-
Net assets
-5.9%
£159,707,000 £150,312,000
-
Employees
+6.8%
118 126
-
Operating profit
+342.8%
£1,216,000 £5,385,000
-
Profit before tax
+713.4%
£2,759,000 £22,441,000
-
Wages
+26.7%
£5,333,000 £6,756,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers